MENU
+Compare
NONOF
Stock ticker: OTC
AS OF
Apr 23 closing price
Price
$61.50
Change
+$0.50 (+0.82%)
Capitalization
266.85B

NONOF Novo-Nordisk A/S Forecast, Technical & Fundamental Analysis

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world... Show more

NONOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NONOF with price predictions
Apr 23, 2025

NONOF's RSI Indicator climbs out of oversold territory

The RSI Indicator for NONOF moved out of oversold territory on April 21, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 8 similar instances when the indicator left oversold territory. In of the 8 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where NONOF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NONOF just turned positive on April 22, 2025. Looking at past instances where NONOF's MACD turned positive, the stock continued to rise in of 60 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NONOF advanced for three days, in of 258 cases, the price rose further within the following month. The odds of a continued upward trend are .

NONOF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NONOF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NONOF entered a downward trend on April 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.361) is normal, around the industry mean (14.056). P/E Ratio (17.663) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.898) is also within normal values, averaging (1.788). Dividend Yield (0.027) settles around the average of (0.025) among similar stocks. P/S Ratio (6.143) is also within normal values, averaging (252.992).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NONOF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NONOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published Dividends

NONOF paid dividends on August 18, 2021

Novo-Nordisk A/S NONOF Stock Dividends
А dividend of $7.00 per share was paid with a record date of August 18, 2021, and an ex-dividend date of August 16, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STSCX34.72N/A
N/A
Sterling Capital SmCp Val Instl
JDSCX28.46N/A
N/A
JPMorgan Small Cap Blend I
DGIFX21.42N/A
N/A
Disciplined Growth Investors
PIIDX13.32N/A
N/A
Principal International Equity R-6
CGLAX15.50N/A
N/A
Calvert Global Equity Fund Class A

NONOF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NONOF has been closely correlated with NVO. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NONOF jumps, then NVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NONOF
1D Price
Change %
NONOF100%
+0.82%
NVO - NONOF
70%
Closely correlated
+2.32%
LABFF - NONOF
23%
Poorly correlated
N/A
IMRN - NONOF
22%
Poorly correlated
-0.71%
QSI - NONOF
21%
Poorly correlated
+3.10%
VRTX - NONOF
21%
Poorly correlated
+0.40%
More

Groups containing NONOF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NONOF
1D Price
Change %
NONOF100%
+0.82%
Pharmaceuticals
category (304 stocks)
14%
Poorly correlated
+0.90%